PUBLICATIONS AND PATENTS

SELECTED PUBLICATIONS

Santana-Magal N, Farhat-Younis L, Gutwillig A, Gleiberman A, Rasoulouniriana D, Tal L, et al. Melanoma-Secreted Lysosomes Trigger Monocyte-Derived Dendritic Cell Apoptosis and Limit Cancer Immunotherapy. Cancer Res. 2020;80(10):1942-56
D. Rasoulouniriana, N. Santana-Magal, A. Gutwillig, Y. Wine, C. Saperia, L. Farchat, Tal. L., H. Gutman, R. Brenner, P. Rider, Carmi Y. A distinct subset of FcγRI-expressing Th1 cells exert antibody-mediated cytotoxic activity. 2019, The Journal of Clinical Investigation 129(10):4151–4164.
MH. Spitzer* and Y. Carmi*, NE. Reticker-Flynn, D. Madhireddy, PF. Gherardini, J. Chabon, GP. Nolan and EG. Engleman. Modeling effective cancer immunotherapy reveals the importance of systemic immunity. Cell. 2017. I
Rider P. Carmi Y. Cohen I. 2016. Biologics for targeting inflammatory cytokines, clinical uses, and limitations. International Journal of Cell Biology Article ID 9259646
Santana-Magal N., Rasoulouniriana D., Vladimirsky J., Rider P., Carmi Y. 2017. Isolation of monocyte-derived dendritic cells and their activation with tumor immune complexes. 2017. JoVE
Carmi Y., Prestwood TR., Spitzer M.H., Linde I.L., Chabon J., Reticker-Flynn N.E., Bhattacharya N., Zhang H., Zhang X., Basto P.A., Burt B.M., Alonso M.N., and Engleman. E.G. Akt and SHP1 are dendritic cell-intrinsic checkpoints for tumor immunity. 2016. JCI Insight. 3; 1(18): e89020
Rider P* and Carmi Y*, Yossef R, Guttman O, Eini H, Azam T, Dinarello CA, Lewis EC. IL-1 Receptor Antagonist Chimeric Protein: Context-Specific and Inflammation-Restricted Activation. J Immunol. 2015 Aug 15;195(4):1705-12.
Carmi, Y., Spitzer, M.H., Linde, I.L., Burt, B.M., Prestwood, T.R., Perlman, N., Davidson, M.G., Kenkel, J.A., Segal, E., Pusapati, G.V., et al. 2015. Allogeneic IgG combined with dendritic cell stimuli induce antitumour T-cell immunity. Nature. 521:99-104. (IF:41.45, cited:19)
Rider, P. and Carmi, Y., Guttman, O., Braiman, A., Cohen, I., Voronov, E., White, M.R., Dinarello, C.A., and Apte, R.N. 2011. IL-1a and IL-1b recruit different myeloid cells and promote different stages of sterile inflammation. J Immunol 187:4835-4843.

Patents

Carmi Y, Rider P. and Rasuluniriana D. T cell expressing an Fc gamma and a method thereof. 62/820,357
Carmi Y, Rider P. and Rasuluniriana D. and Tal L. Multi subunit protein modules, cells expressing same and uses thereof 2020

Carmi Lab

Cancer Immunobiology and Immunotherapy

SELECTED PUBLICATIONS

Santana-Magal N, Farhat-Younis L, Gutwillig A, Gleiberman A, Rasoulouniriana D, Tal L, et al. Melanoma-Secreted Lysosomes Trigger Monocyte-Derived Dendritic Cell Apoptosis and Limit Cancer Immunotherapy. Cancer Res. 2020;80(10):1942-56

D. Rasoulouniriana, N. Santana-Magal, A. Gutwillig, Y. Wine, C. Saperia, L. Farchat, Tal. L., H. Gutman, R. Brenner, P. Rider, Carmi Y. A distinct subset of FcγRI-expressing Th1 cells exert antibody-mediated cytotoxic activity. 2019, The Journal of Clinical Investigation 129(10):4151–4164.

MH. Spitzer* and Y. Carmi*, NE. Reticker-Flynn, D. Madhireddy, PF. Gherardini, J. Chabon, GP. Nolan and EG. Engleman. Modeling effective cancer immunotherapy reveals the importance of systemic immunity. Cell. 2017. I

Rider P. Carmi Y. Cohen I. 2016. Biologics for targeting inflammatory cytokines, clinical uses, and limitations. International Journal of Cell Biology Article ID 9259646

Santana-Magal N., Rasoulouniriana D., Vladimirsky J., Rider P., Carmi Y. 2017. Isolation of monocyte-derived dendritic cells and their activation with tumor immune complexes. 2017. JoVE

Carmi Y., Prestwood TR., Spitzer M.H., Linde I.L., Chabon J., Reticker-Flynn N.E., Bhattacharya N., Zhang H., Zhang X., Basto P.A., Burt B.M., Alonso M.N., and Engleman. E.G. Akt and SHP1 are dendritic cell-intrinsic checkpoints for tumor immunity. 2016. JCI Insight. 3; 1(18): e89020

Rider P* and Carmi Y*, Yossef R, Guttman O, Eini H, Azam T, Dinarello CA, Lewis EC. IL-1 Receptor Antagonist Chimeric Protein: Context-Specific and Inflammation-Restricted Activation. J Immunol. 2015 Aug 15;195(4):1705-12.

Carmi, Y., Spitzer, M.H., Linde, I.L., Burt, B.M., Prestwood, T.R., Perlman, N., Davidson, M.G., Kenkel, J.A., Segal, E., Pusapati, G.V., et al. 2015. Allogeneic IgG combined with dendritic cell stimuli induce antitumour T-cell immunity. Nature. 521:99-104. (IF:41.45, cited:19)

Rider, P. and Carmi, Y., Guttman, O., Braiman, A., Cohen, I., Voronov, E., White, M.R., Dinarello, C.A., and Apte, R.N. 2011. IL-1a and IL-1b recruit different myeloid cells and promote different stages of sterile inflammation. J Immunol 187:4835-4843.

Patents